- Видео 87
- Просмотров 26 864
CELLIMA
Германия
Добавлен 28 янв 2022
CELLIMA provides scientific consulting and technology assessment for early pharmaceutical research and cell biology.
CELLIMA specializes in high content analysis, primary high throughput screening and high resolution microscopy.
CELLIMA helps you develop science-based solutions for automation and miniaturization concepts for primary high-throughput screening.
CELLIMA also supports you in organizing and coordinating interdisciplinary research and technology projects.
CELLIMA's experts have over twenty years of experience in academic and industrial research. During this time, they have developed high-level expertise in high-content analysis and primary high-throughput screening, high-resolution microscopy, cell biology, and automated imaging solutions.
CELLIMA specializes in high content analysis, primary high throughput screening and high resolution microscopy.
CELLIMA helps you develop science-based solutions for automation and miniaturization concepts for primary high-throughput screening.
CELLIMA also supports you in organizing and coordinating interdisciplinary research and technology projects.
CELLIMA's experts have over twenty years of experience in academic and industrial research. During this time, they have developed high-level expertise in high-content analysis and primary high-throughput screening, high-resolution microscopy, cell biology, and automated imaging solutions.
Advancing Drug Discovery: The Promise and Challenges of 3D Cell Models
Insights into Drug Discovery with Eugenio Fava
Join renowned scientist Eugenio Fava as he delves into the intricacies of the drug discovery process. With his extensive expertise in neuroscience and pharmaceutical research, Eugenio provides a deep dive into strategic approaches for understanding diseases, identifying key targets, and developing effective drugs using advanced technologies.
Key Highlights:
• Academic vs. Industry Roles: Compare the unique challenges and contributions of academic institutions and pharmaceutical companies in drug discovery.
• Cutting-Edge Technologies: Learn about the critical role of artificial intelligence, innovative 3D cell models, stem cell technologies, and ...
Join renowned scientist Eugenio Fava as he delves into the intricacies of the drug discovery process. With his extensive expertise in neuroscience and pharmaceutical research, Eugenio provides a deep dive into strategic approaches for understanding diseases, identifying key targets, and developing effective drugs using advanced technologies.
Key Highlights:
• Academic vs. Industry Roles: Compare the unique challenges and contributions of academic institutions and pharmaceutical companies in drug discovery.
• Cutting-Edge Technologies: Learn about the critical role of artificial intelligence, innovative 3D cell models, stem cell technologies, and ...
Просмотров: 21
Видео
Hürden in der Medizinischen Entwicklung
Просмотров 1919 часов назад
Folge 06 des Interviews mit Thomas Müller: Allosterische Modulation - Feinabstimmung für optimale Wirkung In dieser Folge betrachten wir das Prinzip der allosterischen Aktivierung und Modulation von Enzymen und untersuchen, wie es im Zusammenhang mit Ionenkanälen angewendet wird. Thomas Müller erklärt, wie allosterische Modulatoren die Funktion von Ionenkanälen beeinflussen, indem sie an Stelle...
Unlocking Disease Progression Insights: AI and Neural Networks in Clinical Research
Просмотров 721 час назад
Insights into Drug Discovery with Eugenio Fava Join renowned scientist Eugenio Fava as he delves into the intricacies of the drug discovery process. With his extensive expertise in neuroscience and pharmaceutical research, Eugenio provides a deep dive into strategic approaches for understanding diseases, identifying key targets, and developing effective drugs using advanced technologies. Key Hi...
Biolumineszenz & Optogenetik
Просмотров 1614 дней назад
Folge 05 des Interviews mit Thomas Müller: Wie Optogenetik und Biolumineszenz - Licht ins Dunkel der Zellforschung bringen Diesmal sprechen wir über die spannende Welt der Optogenetik, einer innovativen Methode, die mit Hilfe von Biolumineszenz die Funktionen von Ionenkanälen in Zellen präzise untersucht. Thomas Müller erklärt, wie diese Technik es ermöglicht, zelluläre Prozesse mit bisher uner...
AI in Drug Discovery: Harnessing Machine Learning and Deep Learning for Breakthroughs
Просмотров 1014 дней назад
Insights into Drug Discovery with Eugenio Fava Join renowned scientist Eugenio Fava as he delves into the intricacies of the drug discovery process. With his extensive expertise in neuroscience and pharmaceutical research, Eugenio provides a deep dive into strategic approaches for understanding diseases, identifying key targets, and developing effective drugs using advanced technologies. Key Hi...
Ionenkanäle im HTS
Просмотров 4521 день назад
Folge 04 des Interviews mit Thomas Müller: Effizienz in der Ionenkanalforschung mit Hochdurchsatz-Screening Heute werfen wir einen spannenden Blick auf das Hochdurchsatz-Screening und wie es die pharmazeutische Forschung voranbringt. Thomas Müller erklärt, wie Bayer mit modernsten Technologien Millionen von Substanzen in nur einer Woche testen kann. Das beschleunigt die Medikamentenentwicklung ...
Navigating the Essentials: Must-Have vs. Nice-to-Have Technologies in Drug Discovery
Просмотров 1021 день назад
Insights into Drug Discovery with Eugenio Fava Join renowned scientist Eugenio Fava as he delves into the intricacies of the drug discovery process. With his extensive expertise in neuroscience and pharmaceutical research, Eugenio provides a deep dive into strategic approaches for understanding diseases, identifying key targets, and developing effective drugs using advanced technologies. Key Hi...
Vielversprechende Ionenkanalforschung
Просмотров 7428 дней назад
Folge 03 des Interviews mit Thomas Müller: Neue Hoffnung für Patienten Diesmal sprechen wir über die wichtige Rolle von Ionenkanälen bei der Entwicklung neuer Medikamente. Thomas Müller zeigt uns, wie die Forschung an diesen winzigen Proteinen zu innovativen Therapien und damit zur Hilfe für Patienten führen kann. Wir beleuchten die neuesten Trends in der Pharmakologie und entdecken, wie modern...
Moderne medizinische Forschung
Просмотров 71Месяц назад
Folge 02 des Interviews mit Thomas Müller: Moderne Technologien in der medizinischen Forschung Heute sprechen wir über moderne Technologien, die in der frühen medizinischen Forschung eingesetzt werden, und wie wir mit ihrer Hilfe grundlegende neue Erkenntnisse gewinnen. Thomas erklärt außerdem die Grundlagen der Funktionsweise von Ionenkanälen im menschlichen Organismus und welchen wichtigen Be...
Transforming Drug Discovery: The Role of AI and RNA-based Therapies
Просмотров 4Месяц назад
Insights into Drug Discovery with Eugenio Fava Join renowned scientist Eugenio Fava as he delves into the intricacies of the drug discovery process. With his extensive expertise in neuroscience and pharmaceutical research, Eugenio provides a deep dive into strategic approaches for understanding diseases, identifying key targets, and developing effective drugs using advanced technologies. Key Hi...
Kanalarbeiter aus Leidenschaft
Просмотров 144Месяц назад
Folge 01 des Interviews mit Thomas Müller zum Thema Ionenkanäle: Wächter der Gesundheit. Heute erzählt Thomas von seinen Anfängen als Student in Heidelberg und Glasgow, wie er sein Interesse für das faszinierende Thema der Ionenkanäle in der medizinischen Forschung entdeckte und zum leidenschaftlichen Kanalforscher wurde. #healthcare #lifesciences #clinicalresearch #bayer
Frontiers in CNS: Unlocking New Horizons in Drug Discovery
Просмотров 6Месяц назад
Frontiers in CNS: Unlocking New Horizons in Drug Discovery
WÄCHTER DER GESUNDHEIT - Ionenkanäle in der frühen Arzneimittelforschung
Просмотров 91Месяц назад
WÄCHTER DER GESUNDHEIT - Ionenkanäle in der frühen Arzneimittelforschung
CELLIMA TALKS V - ENG: Guardians of health: The study of ion channels in early drug discovery.
Просмотров 56Месяц назад
CELLIMA TALKS V - ENG: Guardians of health: The study of ion channels in early drug discovery.
CELLIMA TALKS V - DEU: Wächter der Gesundheit
Просмотров 388Месяц назад
CELLIMA TALKS V - DEU: Wächter der Gesundheit
Unlocking Potential: Drug Discovery's Impact on Neurology, Metabolism, and Oncology
Просмотров 471Месяц назад
Unlocking Potential: Drug Discovery's Impact on Neurology, Metabolism, and Oncology
10 Future Evolution of High-Content Imaging
Просмотров 5362 месяца назад
10 Future Evolution of High-Content Imaging
Navigating the Complexities of Drug Discovery: Overcoming Key Challenges
Просмотров 5052 месяца назад
Navigating the Complexities of Drug Discovery: Overcoming Key Challenges
09 Large Scale Primary High--Content Screening
Просмотров 5302 месяца назад
09 Large Scale Primary High Content Screening
07 First High-Content Imaging Readers
Просмотров 5232 месяца назад
07 First High-Content Imaging Readers
Bridging Academia and Industry in Drug Discovery
Просмотров 5072 месяца назад
Bridging Academia and Industry in Drug Discovery
06 Evolution of High Content Imaging Devices
Просмотров 103 месяца назад
06 Evolution of High Content Imaging Devices
Accelerating Drug Discovery: The Role of Repurposing and Real-World Evidence
Просмотров 23 месяца назад
Accelerating Drug Discovery: The Role of Repurposing and Real-World Evidence
04 Super-Resolution Microscopy for HCI
Просмотров 253 месяца назад
04 Super-Resolution Microscopy for HCI
Efficient Drug Discovery: Bridging Chemistry and Biology
Просмотров 93 месяца назад
Efficient Drug Discovery: Bridging Chemistry and Biology
Difference Between Drug Discovery vs. Drug Development
Просмотров 113 месяца назад
Difference Between Drug Discovery vs. Drug Development
03 Confocal Microscopy for High-Content Imaging
Просмотров 123 месяца назад
03 Confocal Microscopy for High-Content Imaging
Thank you, Stefan and Thomas :)
I’m really glad to see this topic getting more attention. Academia often has groundbreaking discoveries, but they need industry to turn that science into viable treatments. More partnerships, please!
Loved the insights on how academia and industry can complement each other. The challenge now is making sure intellectual property and funding don’t slow down the collaboration process!
I’ve been working with high-content imaging systems for a while now, but learning about the origins of the technology gave me a whole new appreciation. Awesome content
Great discussion! I think more cross-sector partnerships would not only speed up the drug discovery process but also help ensure academic research has a practical impact on real-world problems.
Such a cool deep dive into the evolution of high-content imaging! This video does a fantastic job of explaining the significance of the early models and their impact on research.
The technology behind these imaging readers is fascinating! It’s impressive how much data these systems can capture and analyze in a short amount of time. Great explanation
This really takes me back to the early days of automated microscopy. It’s incredible to see how the first imaging readers set the stage for modern high-throughput screening in drug discovery.
Wow, I had no idea how much of a game-changer these high-content imaging readers were! The way they revolutionized biological research is truly amazing. Thanks for this informative video!
Appreciate the in-depth explanation! High-content imaging is such a complex field, but you’ve made it understandable for someone new like me.
I had no idea high-content imaging could be so powerful. This video does a great job showing its potential for breakthroughs in scientific discovery.
Such an informative video! The way you break down the imaging process is super easy to follow. Definitely going to share this with my lab team
Wow, this really opened my eyes to the immense effort and collaboration needed in drug discovery. It's incredible to think about all the behind-the-scenes work involved in bringing life-saving medications to patients.
CELLIMA TALKS never disappoints! Learning about cellular defense systems and their role in our health was eye-opening. Can't wait for the next episode!
We apologize for the problems with the audio in the first 5 minutes ... which have been solved for the rest of the interview ...